BFCH Closes Ancient Extracts USA Acquisition, Accelerating UNLOCKD's Transition Into a Scalable Consumer Wellness Operating Platform

BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD Inc., announced the successful closing of its acquisition of VerdaGenix, LLC, owner and operator of the Ancient Extracts USA wellness platform. The acquisition adds an established operating platform featuring direct-to-consumer infrastructure, proprietary formulations, intellectual property, supplier relationships, inventory, fulfillment capabilities, digital marketing systems, customer acquisition infrastructure, and a diversified catalogue of more than 20 wellness SKUs already commercialized and in market.

Management believes this acquisition represents a defining milestone in the Company's evolution into a scalable operating platform focused on wellness, performance, functional products, and human optimization. The transaction follows a series of major strategic developments over the past year, including the elimination of more than $2 million in legacy convertible debt obligations, strengthening of the Company's balance sheet and governance infrastructure, restoration of disclosure compliance, acquisition of the EVERMIND™ intellectual property platform, and expansion of executive leadership.

BFCH is now actively transitioning Ancient Extracts into a broader commercialization and expansion phase focused on scaling both direct-to-consumer operations and retail distribution opportunities. The Company confirmed that it is advancing strategic growth capital initiatives designed to support inventory expansion, operational scaling, customer acquisition, retail channel development, and broader commercialization execution. Management believes the completion of the acquisition significantly de-risks the Company’s broader operating strategy by establishing an active commercial foundation upon which future growth initiatives can now be accelerated.

John P. Gorst, Chief Executive Officer of BFCH, stated: "We are not attempting to create a concept from scratch. Ancient Extracts already has operating infrastructure, commercialized products, existing customers, active distribution channels, and a brand foundation capable of meaningful expansion. Just as importantly, we believe the products themselves resonate strongly with consumers and are aligned with major long-term trends surrounding wellness, performance, and human optimization. Our focus now is execution, commercialization scale, and building a significantly larger operating platform around assets we believe possess real long-term value."

Jordan P. Balencic, D.O., Chairman and Chief Science Officer of BFCH, stated: "Closing Ancient Extracts represents a transformational milestone for BFCH and UNLOCKD. We believe we are still in the early stages of building what can become a much larger operating platform centered around wellness, performance, functional products, cognitive health, and human optimization. The foundation now being established is significantly stronger than many investors currently appreciate."

The Company expects to announce additional operational milestones, including retail initiatives, strategic partnerships, purchase order activity, expanded distribution opportunities, and broader capital formation initiatives. The Company also confirmed that management continues actively evaluating additional acquisition opportunities, strategic partnerships, operating assets, and commercialization initiatives aligned with its broader long-term strategy. Separately, BFCH received a formal legal opinion from securities counsel concluding that it is not a shell company under Rule 405 of the Securities Act of 1933 based upon its operating strategy, asset base, acquisitions, and ongoing operational activities.